Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hiroshi Kamura"'
Autor:
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Shingo Masuda, Ryosuke Osawa, Naoto Hosokawa, Kei Nakashima, Hiroshi Kamura, Haruki Imura, Hiroki Inoue, Suguru Matsuzaka, Yukihiro Sugimoto, Osamu Kuwamitsu, Iori Motohashi, Toru Morikawa, Rentaro Oda, Yuiko Hoshina, Takashi Matono, Osamu Teshigahara, Eiichiro Sando, Sadaharu Asami, Satoshi Kudo, Noboru Akizuki, Yoshikazu Muto, Tomoichiro Hayakawa, Tomoo Kishaba, Yasuji Ohara, Yoshinao Kubo, Motoi Suzuki, Konosuke Morimoto
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 213-225 (2024)
ABSTRACTBackground This study aimed to evaluate VE of primary, first, and second booster ancestral-strain monovalent mRNA COVID-19 vaccination against symptomatic infections and severe diseases in Japan.Methods We conducted a test-negative case-contr
Externí odkaz:
https://doaj.org/article/f0d9d7b4ce4c4d27992396f58f909022
Autor:
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Mayumi Terada, Takayasu Ito, Hideko Ikeda, Hiroshi Kamura, Iori Motohashi, Yuya Kimura, Masaru Komino, Hiromi Arai, Osamu Kuwamitsu, Nobuhiro Akuzawa, Eiichiro Sando, Toru Morikawa, Haruki Imura, Hiroki Inoue, Tomoichiro Hayakawa, Osamu Teshigahara, Yasuji Ohara, Motoi Suzuki, Konosuke Morimoto
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 288-298 (2023)
Background Evaluating COVID-19 vaccine effectiveness (VE) domestically is crucial for assessing and determining national vaccination policy. This study aimed to evaluate VE of mRNA COVID-19 vaccines in Japan. Methods We conducted a multicenter test-n
Externí odkaz:
https://doaj.org/article/c5e2c260b54845e1b8297de267718e84
Autor:
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Kazuya Suami, Ai Yagiuchi, Yuya Kimura, Masaru Komino, Hiromi Arai, Toru Morikawa, Iori Motohashi, Rei Miyazawa, Tetsu Moriyama, Hiroshi Kamura, Mayumi Terada, Osamu Kuwamitsu, Tomoichiro Hayakawa, Eiichiro Sando, Yasuji Ohara, Osamu Teshigawara, Motoi Suzuki, Konosuke Morimoto
BackgroundAlthough high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines was reported in studies in several countries, data is limited from Asian countries, especially against the Delta (B.1.617.2) variant.Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47e099e57948bb8ec1fe448a3bf67310
https://doi.org/10.1101/2022.01.17.22269394
https://doi.org/10.1101/2022.01.17.22269394
Autor:
Haruka Maeda, Nobuo Saito, Ataru Igarashi, Masayuki Ishida, Kazuya Suami, Ai Yagiuchi, Yuya Kimura, Masaru Komino, Hiromi Arai, Toru Morikawa, Iori Motohashi, Rei Miyazawa, Tetsu Moriyama, Hiroshi Kamura, Mayumi Terada, Osamu Kuwamitsu, Tomoichiro Hayakawa, Eiichiro Sando, Yasuji Ohara, Osamu Teshigahara, Motoi Suzuki, Konosuke Morimoto
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(11)
Background. Although high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines has been reported in studies in several countries, data are limited from Asian countries, especially against the Delta (B.1.617.2) va
Autor:
Yoshiyuki Nakashima, Yosuke Homma, Jin Takahashi, Hiroshi Kamura, Hiraku Funakoshi, Takashi Shiga, Masatomi Ikusaka
Publikováno v:
International Journal of Emergency Medicine
Background The Canadian Triage and Acuity Scale is a valid triage system. The system was translated and implemented in the Japanese emergency departments (EDs) from 2012. This system was named the Japanese Triage and Acuity Scale; however, the valida
Autor:
Hiraku Funakoshi, Takashi Shiga, Yosuke Homma, Yoshiyuki Nakashima, Jin Takahashi, Hiroshi Kamura, Masatomi Ikusaka
Publikováno v:
International Journal of Emergency Medicine; 1/25/2016, Vol. 9, p1-6, 6p